Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57901) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Know error (A55274) - R3 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers (A58996) - R2 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R5 - Effective January 01, 2023 Jan 30, 2023
Billing and Coding: Botulinum Toxin Types A and B Policy (A57185) - R4 - Effective October 01, 2019 Jan 26, 2023
Billing and Coding: JW Modifier Billing Guidelines (A53024) - R5 - Effective January 10, 2023 Jan 23, 2023
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) - R1 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R8 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R9 - Effective January 01, 2023 Jan 18, 2023
Billing and Coding: MolDX: myPap (A55292) - R4 - Effective January 1, 2023 Jan 12, 2023
Billing and Coding: MolDX: SMPD1 Genetic Testing (A55627) - R5 - Effective January 01, 2023 Jan 12, 2023
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R2 - Effective October 1, 2022 Jan 11, 2023
Billing and Coding: MolDX: Pharmacogenomics (A57384) - R7 - Effective December 07, 2022 Jan 11, 2023
Billing and Coding: COMPLEX DRUG Administration Coding (A58532) - R11 - Effective January 01, 2023 Dec 29, 2022
Billing and Coding: Lab: Controlled Substance Monitoring and Drugs of Abuse Testing (A55001) - R15 - Effective October 1, 2022 Dec 29, 2022
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R11 - Effective January 1, 2023 Dec 29, 2022
Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) - (A58133) - R2 - Effective January 1, 2023 Dec 23, 2022
Billing and Coding: Implantable Automatic Defibrillators - (A56340) - R5 - Effective January 1, 2023 Dec 23, 2022
Billing and Coding: Treatment of Varicose Veins of the Lower Extremities - (A57706) - R1 - Effective January 1, 2023 Dec 23, 2022
Billing and Coding: Billing Medicare for the SphenoCath® and Other Similar Devices (A55584) - R5 - Effective January 1, 2023 Dec 22, 2022